Biotech companies in the United States by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Scholar Rock Holding leads the 20 biotech companies in the United States ranked by short interest, at 19.2%, ahead of Twist Bioscience (14.4%) and Kodiak Sciences (12.4%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
20
First
Scholar Rock Holding19.2%
Median
9.77%
Combined market value
SAR 2.76T
Countries
1

Market values as of .

United States
All sectors
Biotech
SAR
Clear filters
Biotech companies in the United States by short interest
#CompanyShort interest % ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Scholar Rock HoldingSRRK · Health Care19.2%SAR 23BSAR 188.92 4.94% up 25% up United States
2Twist BioscienceTWST · Health Care14.4%SAR 28.5BSAR 418.64 4.07% down 291% up United States
3Kodiak SciencesKOD · Health Care12.4%SAR 24BSAR 367.18 0.09% up 371% up United States
4Halozyme TherapeuticsHALO · Health Care12.0%SAR 39.8BSAR 348.96 2.88% down 32% up United States
5ImmunityBioIBRX · Health Care11.9%SAR 26.2BSAR 24.64 1.94% down 216% up United States
6RepligenRGEN · Health Care11.0%SAR 40.8BSAR 638.69 1.38% down 5% up United States
7ExelixisEXEL · Health Care10.5%SAR 60.2BSAR 246.90 3.60% down 55% up United States
8CG OncologyCGON · Health Care10.3%SAR 27.4BSAR 307.17 2.38% up 93% up United States
9Krystal BiotechKRYS · Health Care10.3%SAR 35.1BSAR 1,184.51 0.15% up 49% up United States
10Kymera TherapeuticsKYMR · Health Care9.84%SAR 38.2BSAR 447.78 1.44% down 81% up United States
11VaxcytePCVX · Health Care9.70%SAR 34.6BSAR 218.89 0.27% down 22% up United States
12ImmunovantIMVT · Health Care8.96%SAR 25.2BSAR 121.97 1.96% down 44% up United States
13ModernaMRNA · Health Care8.20%SAR 302.5BSAR 747.61 1.29% up 740% up United States
14Adaptive BiotechnologiesADPT · Health Care7.09%SAR 17BSAR 105.20 1.44% down 51% up United States
15Revolution MedicinesRVMD · Health Care6.05%SAR 129.3BSAR 597.96 0.24% down 125% up United States
16Neurocrine BiosciencesNBIX · Health Care5.83%SAR 59.4BSAR 587.31 3.85% down 10% up United States
17Bio-TechneTECH · Health Care4.90%SAR 42.8BSAR 272.67 0.07% down 18% up United States
18BiogenBIIB · Health Care3.69%SAR 137BSAR 926.89 1.70% down 41% up United States
19AmgenAMGN · Health Care2.33%SAR 890.3BSAR 1,645.84 1.14% down 30% up United States
20Gilead SciencesGILD · Health Care1.72%SAR 774.7BSAR 624.59 1.45% down 31% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7506 SAR).

Questions and answers

Which biotech companies in the United States rank first by short interest?

Scholar Rock Holding (19.2%), Twist Bioscience (14.4%) and Kodiak Sciences (12.4%) are the top three of the 20 biotech companies in the United States ranked by short interest as of the 30 Oct 2026 settlement date.

How many biotech companies in the United States are in this ranking?

20 are ranked by short interest.

What are these biotech companies in the United States worth together?

The 20 biotech companies in the United States ranked by short interest have a combined market value of SAR 2.76T as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Biotech companies in the United States by short interest”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.